About Broadpeak Ventures
Broadpeak Ventures is a venture capital firm founded in 2016. It is primarily based out of Larchmont, United States. It primarily invests in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Telecom and Financial Services. Overall, Broadpeak Ventures portfolio has seen 1 IPO and 2 acquisitions, namely Base Pair Biotechnologies, Visualase and Ceryx. Broadpeak Ventures has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Portfolio IPOs
Broadpeak Ventures' List of Top Investments
Broadpeak Ventures has a portfolio of 8 companies. Their most notable investments include REX Shares and Exact Imaging.Their portfolio spans across United States and Canada. They have invested in Life Sciences, Telecom, Financial Services. Here is the list of top investments by Broadpeak Ventures:1. REX Shares
REX Shares provides a cryptocurrency exchange-traded fund. The fund can be utilized to invest in crypto and blockchain companies. It offers BKKC ETF, VolMAXX and Microsectors as their products.
Key facts about REX Shares
- Founded Year: 2014
- Location: New York City (United States)
- Stage: Seed
- Total Funding till date: $3.49M
- Employee Count: 40 as on Aug 31, 2026
- Investors: FinRebel and Broadpeak Ventures
- Latest Funding Round: Seed, Sep 27, 2018, $*****
- Highlight: Editors' Pick
Exact Imaging has developed a micro-ultrasound based imaging device. The ExactVu system operates at 29MHz waves for higher resolution and is used for imaging prostate cancer and biopsies. The product has an integrated disposable needle biopsy apparatus for visualization and targeting of suspicious small regions. in real-time
Key facts about Exact Imaging
- Founded Year: 2013
- Location: Markham (Canada)
- Stage: Series D
- Total Funding till date: $39.9M
- Employee Count: 47 as on Aug 31, 2026
- Investors: Graphite Ventures, Veddis App and 9 Others
- Latest Funding Round: Series D, Feb 10, 2026, $*****
- Highlight: Editors' Pick
3. Tenzing
Tenzing is a provider of managed IT services offering hosting and infrastructure solutions to retailers and manufacturers. Implements and manages e-commerce platforms with software from Oracle, Magento, Hybris, and IBM. Manage services include managed hosting, IT infrastructure services, managed cloud services, and AWS managed services in partnership with Amazon. Also, offers performance management, and enterprise security services. One-Eighty corp, Desato, and Zeal Optics are among the customers.
Key facts about Tenzing
- Founded Year: 1998
- Location: Toronto (Canada)
- Stage: Series B
- Total Funding till date: $28.2M
- Employee Count: 9 as on Aug 31, 2026
- Investors: Riverside Management Group, Eventi Capital Partners and 1 Other
- Latest Funding Round: Series B, Jul 21, 2015, $*****
Aptamer discovery and development services for diagnostics, therapeutics, and research. They specialize in custom aptamer solutions, offering services from initial discovery to functional testing and maturation. Their expertise includes aptamer selection, bioinformatics, affinity determination, and assay development. They provide reagents, cell culture services, and binding services. They focus on aptamer applications in drug discovery, therapeutic development, biomarker detection, and environmental testing. They offer innovative technologies like Multiplex SELEX and customized solutions to address project challenges. They aim to deliver effective aptamers for real-world applications, supporting clients through every phase of development, from needs definition to functional evaluation.
Key facts about Base Pair Biotechnologies
- Founded Year: 2011
- Location: Pearland (United States)
- Stage: Public
- Total Funding till date: $5.06M
- Employee Count: 8 as on Aug 31, 2026
- Investors: Eventi Capital Partners, Broadpeak Ventures and 2 Others
- Latest Funding Round: Grant (prize money), Jul 22, 2025, $*****
- Highlight: Public
5. Visualase
Medical technology company specializing in innovative healthcare solutions globally. They are dedicated to advancing health through a wide array of medical devices and therapies. Their offerings span across various specialities including neurological, cardiac, spinal, surgical, and diabetes-related products. They cater to both healthcare professionals and patients, providing resources, education, and support services. They focus on improving patient outcomes through cutting-edge technology and comprehensive care solutions. They operate globally, serving diverse markets with a commitment to quality, ethics, and innovation in the medical field. They also focus on digital ordering and services, reimbursement, and patient services.
Key facts about Visualase
- Founded Year: 2005
- Location: Houston (United States)
- Stage: Acquired
- Total Funding till date: $4.77M
- Employee Count: 7 as on May 31, 2026
- Investors: Eventi Capital Partners and Broadpeak Ventures
- Latest Funding Round: Series A, Dec 05, 2012, $*****
- Highlight: Acquired
IPOs and Publicly Listed companies in Broadpeak Ventures' Portfolio
1 of Broadpeak Ventures' portfolio company became public - Base Pair Biotechnologies.Here are Broadpeak Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
- | - | - | 4426 |
Acquired companies in Broadpeak Ventures' Portfolio
2 companies from Broadpeak Ventures' portfolio have been acquired. The most recent acquisition was Ceryx in Apr 2016 by Dimension Data for $*****.Here are Broadpeak Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 04, 2016 | - | - | 5737 | |
Jul 28, 2014 | - | - | 4719 |
Team profile of Broadpeak Ventures
Broadpeak Ventures has a team of 1 member located in United States. Broadpeak Ventures' team does not sit on the board of any company as of now.Recent News related to Broadpeak Ventures
•
Oxbridge Re signs up new directorReinsurance News•Jan 17, 2023•Oxbridge Re Holdings, Broadpeak Ventures
